WuXi XDC Cayman Inc
HKEX:2268
WuXi XDC Cayman Inc
Revenue
WuXi XDC Cayman Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Revenue
¥990.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Revenue
¥39.4B
|
CAGR 3-Years
29%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Revenue
¥11.5B
|
CAGR 3-Years
27%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Revenue
¥17B
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Revenue
¥7.2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
24%
|
CAGR 10-Years
34%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Revenue
¥4.2B
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WuXi XDC Cayman Inc's Revenue?
Revenue
990.4m
CNY
Based on the financial report for Dec 31, 2022, WuXi XDC Cayman Inc's Revenue amounts to 990.4m CNY.
What is WuXi XDC Cayman Inc's Revenue growth rate?
Revenue CAGR 1Y
218%
Over the last year, the Revenue growth was 218%.